Bulletin
Investor Alert

Vertex Pharmaceuticals Inc.

NAS: VRTX

GO
/marketstate/country/us

After Hours

/zigman2/quotes/202259802/composite

$

312.20

Change

-0.02 -0.0064%

Volume

Volume 114,802

Dec 9, 2022, 7:59 p.m.

Quotes are delayed by 20 min

/zigman2/quotes/202259802/composite

Previous close

$ 321.32

$ 312.22

Change

-9.10 -2.83%

Day low

Day high

$311.79

$321.15

Open
Open: 319.30

52 week low

52 week high

$204.11

$324.75

Open

Market cap

$82.48B

Average volume

1.48M

P/E ratio

24.64

Rev. per Employee

$2.20M

EPS

12.67

Dividend

N/A

Div yield

N/A

Ex dividend date

N/A

Compare:
Indexes
  • Dow(INDU) INDU
  • Nasdaq (COMP) COMP
  • S&P 500 (SPX) SPX
  • Global Dow (GDOW) GDOW
1d
5d
3m
6m
1y
3y
5y
/news/latest/company/us/vrtx

MarketWatch News on VRTX

  1. Vertex Pharmaceuticals Inc. stock rises Wednesday, outperforms market

    5:44 p.m. Dec. 7, 2022

    - MarketWatch Automation

  2. Vertex Pharmaceuticals Inc. stock rises Friday, outperforms market

    5:45 p.m. Dec. 2, 2022

    - MarketWatch Automation

  3. Vertex Pharmaceuticals Inc. stock rises Thursday, outperforms market

    5:44 p.m. Dec. 1, 2022

    - MarketWatch Automation

  4. Vertex Pharmaceuticals Inc. stock falls Wednesday, underperforms market

    5:30 p.m. Nov. 23, 2022

    - MarketWatch Automation

  5. Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day

    5:30 p.m. Nov. 22, 2022

    - MarketWatch Automation

  6. Vertex Pharmaceuticals Inc. stock outperforms market on strong trading day

    5:29 p.m. Nov. 18, 2022

    - MarketWatch Automation

  7. Vertex Pharmaceuticals Inc. stock falls Tuesday, underperforms market

    5:29 p.m. Nov. 15, 2022

    - MarketWatch Automation

  8. Vertex Pharmaceuticals Inc. stock falls Friday, underperforms market

    5:29 p.m. Nov. 11, 2022

    - MarketWatch Automation

  9. Loading more headlines...

Analyst Ratings

/news/nonmarketwatch/company/us/vrtx

Other News on VRTX

  1. 3 Reasons Growth Investors Will Love Vertex (VRTX)

    12:45 p.m. Dec. 8, 2022

    - Zacks.com

  2. Esperion (ESPR) Reports Positive Data From CLEAR Study

    10:04 a.m. Dec. 8, 2022

    - Zacks.com

  3. 2 Sector ETFs Hovering Around a 52-Week High

    1:00 p.m. Dec. 6, 2022

    - Zacks.com

  4. GSK's Myelofibrosis Candidate MAA Gets Accepted in Europe

    10:36 a.m. Dec. 5, 2022

    - Zacks.com

  5. AstraZeneca (AZN) Boosts Cell Therapies With Neogene Deal

    8:34 a.m. Nov. 30, 2022

    - Zacks.com

  6. Loading more headlines...
/news/pressrelease/company/us/vrtx

Press Releases on VRTX

  1. Nasdaq 100 Movers: VRTX, JD

    10:27 a.m. Nov. 11, 2022

    - MarketNewsVideo.com

  2. Vertex to Participate in Upcoming Investor Conferences

    8:00 a.m. Nov. 9, 2022

    - BusinessWire - BZX

  3. Vertex Reports Third Quarter 2022 Financial Results

    3:01 p.m. Oct. 27, 2022

    - BusinessWire - BZX

  4. Nasdaq 100 Movers: PDD, VRTX

    9:49 a.m. Oct. 24, 2022

    - MarketNewsVideo.com

  5. Vertex to Announce Third Quarter 2022 Financial Results on October 27

    3:05 p.m. Oct. 13, 2022

    - BusinessWire - BZX

  6. Consider Vertex Stock If Missed Out On Axsome Stock

    12:00 p.m. Oct. 12, 2022

    - PressReach.com

  7. Vertex Advances Program Targeting Alpha-1 Antitrypsin Deficiency

    7:00 a.m. Oct. 11, 2022

    - BusinessWire - BZX

  8. Vertex Appoints Jonathan Biller as Chief Legal Officer

    8:00 a.m. Sept. 8, 2022

    - BusinessWire - BZX

  9. Loading more headlines...

Rates »

Link to MarketWatch's Slice.